A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

NCT06333028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2025-05-02

No results posted yet for this study

Summary

A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract Extraction

Conditions

  • Cataract

Interventions

DEVICE

enVista Aspire EA IOLs

Subjects bilaterally implanted with enVista Aspire EA IOLs

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-30
Primary Completion
2025-03-13
Completion
2025-03-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06333028 on ClinicalTrials.gov